Taking estrogen without progestin for four or more years after menopause increases women's chances of developing ovarian cancer, but women who take both hormones do not appear to be at greater risk ...

Postmenopausal patients with ovarian or endometrial cancer who received conjugated equine estrogen may have increased mortality rates. For patients with ovarian and endometrial cancer, receiving ...

WASHINGTON Taking estrogen for 10 years or more after menopause doubled women's risk of fatal ovarian cancer, says a new study that adds to the confusion facing millions of Americans debating whether ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- Use ...

Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial The ASTRRA trial highlights both the power ...

After ovary removal to prevent cancer, the sudden loss of estrogen reshaped my health and life, showing the need for better care and awareness for women like me. "The ovaries don't just grow egg cells ...

Obesity is a growing crisis in India, significantly increasing the risk of at least 12 cancers. Fat cells actively promote cancer growth through hormones and inflammation. Bariatric surgery offers a ...

An open, prospective, single arm, phase II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) with neoadjuvant chemotherapy in patients with advanced ovarian cancer: Interim analysis from the ...

How to navigate an early-in-life breast cancer diagnosis, from fertility concerns to career questions: What the research ...